Subscribe for the newsletter
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Novel Nucleoside Analogs
Sort By
Newest First
Sign in
1 / 1
1 / 1
Novel Nucleoside
Transposon Therapeutics Acquired a Portfolio of Novel Nucleoside Analogs for Oncology To Enhance Development Pipeline
Transposon Therapeutics
PR-11-24-NI-119
Nov 21, 2024
